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Abstract
Objectives—There are growing concerns about nonmedical use of ADHD stimulants among 
adolescents; yet, little is known whether there exist heterogeneous subgroups among adolescents 
with nonmedical ADHD stimulant use according to their concurrent substances use.
Methods—We used latent class analysis (LCA) to examine patterns of past-year problematic 
substance use (meeting any criteria for abuse or dependence) in a sample of 2,203 adolescent 
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participants from the National Surveys on Drug Use and Health 2006–2011 who reported past-
year nonmedical use of ADHD stimulants. Multivariable latent regression was used to assess the 
association of socio-demographic characteristics, mental health and behavioral problems with the 
latent classes.
Results—The model fit indices favored a four-class model, including a large class with frequent 
concurrent use of alcohol and marijuana (Alcohol/Marijuana class; 41.2%), a second large class 
with infrequent use of other substances (Low substance class, 36.3%), a third class characterized 
by more frequent misuse of prescription drugs as well as other substances (Prescription drug+ 
class; 14.8%), and finally a class characterized by problematic use of multiple substances 
(Multiple substance class; 7.7%). Compared with individuals in Low substance class, those in the 
other three classes were all more likely to report mental health problems, deviant behaviors and 
substance abuse service use.
Conclusions—Adolescent nonmedical ADHD stimulants users are a heterogeneous group with 
distinct classes with regard to concurrent substance use, mental health and behavioral problems. 
The findings have implications for planning of tailored prevention and treatment programs to curb 
stimulant use for this age group.
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1. Introduction
Nonmedical use of prescription stimulants, especially stimulants prescribed for the treatment 
of Attention Deficit Hyperactivity Disorder (ADHD), has received increased research 
attention in the past decade.1-4 These stimulants, including methylphenidate and mixed salts 
amphetamines, are classified as schedule II substances in the US Controlled Substances Act 
(CSA) due to their high abuse potential.5
Past research has reported an increase in nonmedical prescription stimulant use among 
young adults and adolescents.6-12 According to data from the Monitoring The Future (MTF) 
survey, past-year nonmedical use of methylphenidate in high school seniors increased from 
0.5% in 1995 to 2.5% in 2002.10 In another high school survey, 4.5% of students reported 
using prescription stimulants nonmedically in their lifetime, with 23.3% reporting being 
approached to sell, give, or trade these drugs.12 Emergency room visits involving ADHD 
stimulants tripled in the period between 2005 and 2010,13 highlighting the health burden of 
nonmedical use of these medications.
Evidences supported that nonmedical ADHD stimulant users are more likely to use other 
substances or to engage in risky behaviors.1, 6, 11-12, 14 Among high school students, 
nonmedical prescription stimulant users reported significantly higher rates of alcohol and 
other drug use than nonusers.12 In a college-based survey, nonmedical prescription stimulant 
users were more likely to report use of alcohol, cigarettes, illegal drugs, and to engage in 
other risky behaviors.2 Despite the growing evidence for nonmedical use of stimulants, 
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relatively little is known regarding the concurrent substance use patterns among adolescent 
who use prescription stimulants nonmedically.
In this study, we aimed to explore the subgroups of nonmedical adolescent ADHD stimulant 
users based on their concurrent problematic substance use using data from national surveys. 
We further examined variations in socio-demographic characteristics, mental health profiles, 
deviant behaviors, and service use among the empirically identified classes.
2. Methods
2.1 Study sample and measures
Combined annual data from the NSDUH public use data files for the years 2006 to 2011 
(N= 338,495) were analyzed. The study sample was restricted to participants aged 12 to 17 
(N=109,466) who reported using ADHD stimulants nonmedically in the past year 
(N=2,203). The NSDUH is an annual cross-sectional survey sponsored by the Substance 
Abuse and Mental Health Administration (SAMHSA) and is designed to provide estimates 
of the prevalence of alcohol and drug use in the household population of the United States, 
12 years of age and older. The response rate for household screening ranged from 87% to 
91% and for completed interviews from 74% to 76% across the 6 years. Survey items were 
administered by computer-assisted personal interviewing (CAPI) conducted by an 
interviewer and audio computer-assisted self-interviewing (ACASI) for sensitive questions. 
Detailed information about the sampling and survey methodology of the NSDUH can be 
found elsewhere.15-20
2.1.1 Assessment of past-year nonmedical ADHD stimulant use—For the current 
analyses, ADHD stimulants were defined as stimulants with specific indications for 
treatment of ADHD, and included Ritalin® or methylphenidate, Cylert®, Dexedrine®, 
Dextroamphetamine, Adderall®, and Vyvanse®. The survey used the following question to 
assess lifetime nonmedical use of any ADHD stimulants: “Have you ever, even once, used 
Ritalin or methylphenidate that was not prescribed for you or that you took only for the 
experience or feeling it caused?” Nonmedical ADHD stimulant use was defined as past-year 
use if the time since last use was within the prior 12 months.
2.1.2 Assessment of socio-demographic characteristics—Socio-demographic 
variables included in the analyses were sex, age (12-13,14-15,16-17), race/ethnicity (non-
Hispanic white, racial/ethnic minority), school dropout, average grade (C and above, D or 
lower) in the last period completed, and annual household income (≤ $19,999, $20,000-
$34,999, $35,000-$69,999, ≥ $70,000). These variables were chosen based on past research 
on correlates of substance use in adolescents.21
2.1.3 Assessment of past-year problematic substances use—Past-year 
problematic substance use was defined by fulfilling any of the criteria for past-year 
substance abuse or dependence based on the Diagnostic and Statistical Manual of Mental 
Disorders –IV (DSM-IV).22 The substances examined included alcohol, marijuana, cocaine, 
heroin, hallucinogens, inhalants, prescription opioids, and prescription tranquilizers/
sedatives (combined).
Chen et al. Page 3









2.1.4 Assessment of past-year mental health and deviant behavior variables—
Mental health variables included were past-year clinician-identified anxiety disorder or 
depression Past-year mental health and substance use disorder (SUD) service use were 
ascertained by asking participants whether they received any mental health treatment or 
SUD treatment in the past year. Past-year deviant behaviors were ascertained by asking 
participants how many times they had attacked someone, sold drugs and stolen anything 
worth more than $50 over the year. Consistent with past research,23 participants who 
reported any of the three behaviors were categorized as having deviant behaviors (0 for none 
of these behaviors and 1 for 1 time or more). Past-year arrest was defined by having been 
arrested and charged with lawbreaking (not counting minor traffic violations; 0 for none and 
1 for at least once). Past-year sexually transmitted disease (STD) was also assessed based on 
participant self-reports of diagnosis by a medical professional.
2.2 Statistical analyses
Complex latent class analysis (LCA)24,25 as implemented in the Mplus software26 was used 
to identify subgroups according to concurrent problematic substance use among adolescents 
who reported using ADHD stimulants nonmedically in the past year. The LCA analysis was 
based on eight dichotomous substance use indicators (past-year problematic use of alcohol, 
marijuana, cocaine, heroin, hallucinogens, inhalants, prescription opioids, and tranquilizers/
sedatives).
We performed LCA for 1 to 6 classes in order to ascertain the model with the optimal fit 
based on fit indices. Minimum values of the Bayesian Information Criterion (BIC) was 
given priority over other fit indices such as Akaike Information Criterion (AIC) and Sample 
Size Adjusted BIC (ABIC), given BIC's more stable performance in simulation studies.27 
We also considered the class size and clinical interpretability in selecting the model.
Once the number of classes was ascertained, correlates including socio-demographic 
characteristics, mental health and behavioral problems were incorporated into the models 
using unadjusted and adjusted multinomial regressions.28 These analyses were conducted 
using a modal assignment latent regression approach with Stata 13.0 software.29 A p<0.05 
was used to ascertain the statistical significance of findings.
3. Results
3.1 Subtypes of nonmedical ADHD stimulant users
Approximately 3.2% (n = 2,203) of adolescent participants from the NSDUH 2006 to 2011 
reported nonmedical use of ADHD stimulants in the past year. The most commonly used 
substance among nonmedical ADHD stimulant users was problematic use of alcohol 
(53.3%), followed by problematic use of marijuana (47.9%), pain relievers (23.4%), 
hallucinogens (12.4%), tranquilizers and sedatives (9.9%), cocaine (7.3%), inhalants (5.8%) 
and heroin (1.7%). A 4-class model was chosen by taking into account the value of BIC as 
well as the clinical interpretability.27 Figure 1 presents the prevalence of problematic use of 
different substances in the four classes of nonmedical ADHD stimulant users. Class 1 
constituted 36.3% of the sample, and was comprised of individuals with low probabilities of 
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problematic use of alcohol and prescription opioids and near zero probabilities of other 
problematic substance use (Low substance class). Class 2 made up 14.8% of the study 
sample and included individuals with high probabilities of problematic use of alcohol and 
marijuana, moderate probabilities of problematic use of inhalants and hallucinogens, and 
with high probabilities of problematic use of pain relievers and sedatives/tranquilizers 
(Prescription drug+ class). Class 3 included individuals with high probabilities of 
problematic use of marijuana and alcohol, and was the largest class (Alcohol-marijuana 
class, 41.2%). Finally, class 4 was comprised of individuals who had the highest 
probabilities of problematic use of most of the substances examined (Multiple substance 
class, 7.7%).
3.2 Characteristic of participants in the LCA-defined classes
Table 1 presents the socio-demographic, mental health, service use and deviant behavior 
profiles of the 4 classes of past-year nonmedical ADHD stimulant users. The Prescription 
drug+, Alcohol-marijuana, and Multiple substance classes showed particularly high 
prevalence of deviant behaviors (60.3%-85.5%) and arrest (23.6%- 34.2%). Furthermore, 
46.4% of those in the Prescription drug+ class reported past-year mental health service use 
and 27.1% reported a depression diagnosis.
Compared to the Low substance class, participants in all three other classes were more likely 
to report past-year depression (aORs=1.97 to 2.89), SUD treatment (aORs=2.97 to 7.30), 
deviant behaviors (aORs=4.80 to 14.52) and arrest (aOR=2.38 to 2.51). In addition, the 
adolescents in the Prescription drug+ class were more likely to be female (aOR=1.69, 95% 
CI=1.16, 2.45) and adolescents in the Alcohol-marijuana class were typically older than 
those in the Low substance class (16-17 years age group compared to 12-13 years age group; 
aOR=3.84, 95% CI=1.53, 9.61).
4. Discussion
This study found that more than half of nonmedical adolescent ADHD stimulant users 
reported concurrent problematic substance use with the most frequently used substances 
being alcohol (53.3% of nonmedical ADHD stimulant users), marijuana (47.9%) and pain 
relievers (23.4%). We also found that with regard to concurrent problematic substance use, 
nonmedical ADHD stimulant users are a heterogeneous group encompassing four classes 
with distinct psychiatric and social profiles, which has implications for risk evaluation and 
preventive strategy development.
The classes that we labeled as Prescription drug+, Alcohol-marijuana and Multiple 
substance classes were generally more likely to report mental health problems, SUD service 
use, and deviant behaviors compared to the Low substance class, which had the lowest 
prevalence of concurrent problematic substance use. Similar to previous research,30 our 
study points out that the association with mood disorders may be more pronounced in the 
subgroups that report more concurrent problematic substance use. Consistent with other 
studies that have shown individuals with co-occurring mental and substance disorders have 
higher rates of service use than those without co-occurring disorders,23 a higher prevalence 
of SUD service use was also observed in the three classes identified in the present analyses. 
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Our finding underscores the significance of screening for mental health problems among the 
nonmedical ADHD stimulant users.
Despite the similarities among the three classes with a higher prevalence of concurrent 
substance use problems, especially with regard to psychiatric and behavior profiles, these 
three classes showed some differences in socio-demographic profiles. Most notably, 
participants in the Prescription drug+ class were more likely to be female compared to the 
Low substance use class, while the other two classes did not show such gender differences. 
As a recent review of studies of substance use in adolescents in the U.S. noted, adolescent 
girls are more likely to report nonmedical prescription opioids and tranquilizers use;31 our 
study further shows that adolescent girls are more likely to use these medications even 
among nonmedical stimulant users.
Comorbid substance use and psychiatric disorders confer additional risks not only for worse 
social outcomes but also for poorer SUD treatment response.32,33 Similarly, concurrent use 
of multiple substances is linked to more physical consequences and criminal involvement.34 
These considerations are especially relevant in the case of the Multiple substance class, who 
in addition to a greater burden of mental and substance use problems were also more likely 
to drop out of school. The findings call for a concerted effort to address mental health as 
well as substance use related problems in this vulnerable group of adolescents.
This study has multiple strengths, including a large sample size and generalizability to the 
US household population. However, this study has several limitations. First, all the 
information was based on self-report, which is prone to recall and reporting biases, although 
the validity of substance use reports in NSDUH has been previously established.35 Second, 
the use of a cross-sectional design limits assessment of temporal relationships and causal 
inferences. Third, we used clinician-identified depression and anxiety in this study, which 
are subject to health service access and availability. Fourthly, the information regarding the 
frequency of nonmedical prescription stimulant use was not available, thus whether these 
subgroups differ by their level of severity remains unknown. Lastly, there is lack of 
information regarding the users’ motivations, which could offer implications for prevention 
strategy development.
5. Conclusion
Our results suggest that adolescent nonmedical ADHD stimulant users are a heterogeneous 
group with distinct profiles with regard to concurrent substance use, socio-demographics 
and mental health profiles. Elucidating concurrent substance use patterns among adolescent 
stimulant users is crucial for identifying these subgroups and addressing their special needs.
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More than half of nonmedical adolescent ADHD stimulant users reported concurrent 
problematic substance use.
Adolescent nonmedical ADHD stimulants users are a heterogeneous group with distinct 
classes with regard to concurrent substance use, mental health and behavioral problems.
Multiple substance class were significantly more likely to report mental health and 
behavioral problems, indicating their worse outcome and greater medical need.
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Prevalence of problematic use of other substances in four classes of adolescents with past-
year nonmedical ADHD stimulant use in the 2006–2011 National Survey on Drug Use and 
Health.
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Table 1
Characteristics of past-year nonmedical ADHD stimulant users, by concurrent problematic substance use class 
in a sample of the US population aged 12-17 (N= 2,203): data from 2006-2011 National Survey on Drug Use 
and Health.

































    Male 376(48.0) 136(38.1) 1.00 474(52.3) 1.00 87(46.5) 1.00
Female 408(52.0) 207(61.9) 1.69(1.16,2.45) 422(47.7) 1.02(0.79,1.31) 93(53.5) 1.49(0.89,2.50)
Age
    12-13 87(11.1) 26(11.4) 1.00 17(2.3) 1.00 11(4.4) 1.00
    14-15 226(19.9) 121(32.3) 0.84(0.38,1.85) 225(27.0) 2.65(0.97,7.21) 44(67.1) 1.31(0.40,4.31)
    16-17 471(59.0) 196(56.4) 1.02(0.48,2.14) 654(70.7) 3.84(1.53,9.61) 125(68.5) 2.21(0.68,7.12)
Race
    Non-Hispanic White 595(77.6) 265(79.5) 1.00 725(83.3) 1.00 142(83.438) 1.00
Minorities 189(22.4) 78(20.5) 0.64(0.42,0.99) 171(16.7) 0.67(0.49,0.91) 38(16.6) 0.53(0.29,0.98)
School Dropout
    No 765(97.5) 324(95.3) 1.00 837(93.7) 1.00 162(89.5) 1.00
    Yes 19(2.6) 19(4.7) 1.16(0.40,3.35) 59(6.3) 0.87(0.41,1.86) 18(10.5) 0.76(0.28,2.10)
Average Grade
A,B, and C 713(91.2) 273(81.1) 1.00 759(86.2) 1.00 142(81.8) 1.00
D or lower 71(8.8) 70(18.9) 1.72(0.95,3.10) 137(13.8) 1.35(0.86,2.14) 38(18.2) 1.49(0.73,3.04)
Household Income
<$20,000 103(12.4) 69(19.6) 1.00 105(10.8) 1.00 33(18.9) 1.00
$20,000-$49,999 233(28.1) 111(33.6) 0.76(0.44,1.33) 331(34.4) 1.43(0.94,2.17) 59(26.6) 0.72(0.31,1.71)
$50,000-$74,999 140(15.8) 66(16.0) 0.67(0.35,1.30) 331(34.4) 1.13(0.67,1.91) 26(11.1) 0.68(0.30,1.56)
≥$75,000 308(43.8) 97(30.8) 0.50(0.28,0.91) 308(39.2) 1.05(0.65,1.69) 62(43.4) 0.84(0.34,2.09)
Past-year depression
    No 667(91.9) 237(72.9) 1.00 723(85.0) 1.00 120(68.5) 1.00
    Yes 72(8.1) 86(27.1) 2.89(1.86,4.48) 140(15.0) 1.97(1.25,3.10) 53(31.5) 2.76(1.41,5.40)
Past-year anxiety
    No 739(95.0) 291(86.8) 1.00 825(93.0) 1.00 144(75.6) 1.00
    Yes 45(5.0) 52(13.2) 0.87(0.46,1.64) 71(7.0) 0.72(0.39,1.35) 36(24.4) 1.74(0.76,4.00)
Past-year mental health 
treatment
    No 601(78.6) 178(53.6) 1.00 646(72.9) 1.00 93(61.3) 1.00
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    Yes 166(21.4) 157(46.4) 1.56(0.97,2.49) 241(27.1) 0.97(0.67,1.38) 85(38.7) 1.03(0.59,1.79)
Past-year SUD treatment
    No 754(96.8) 270(79.3) 1.00 769(85.9) 1.00 115(62.2) 1.00
    Yes 30(3.3) 73(20.7) 3.45(2.13,6.93) 127(14.1) 2.97(1.60,5.46) 65(37.8) 7.30(3.73,14.27)
Past-year deviant behaviors
    No 572(73.3) 101(35.2) 1.00 355(39.7) 1.00 25(14.2) 1.00
    Yes 212(26.7) 242(64.8) 4.80(3.08,7.50) 541(60.3) 3.75(2.84,4.94) 155(85.8) 14.52(8.19,25.74)
Past-year arrest
    No 718(92.7) 239(73.7) 1.00 686(76.4 1.00 113(65.8) 1.00
    Yes 66(7.3) 104(26.3) 2.38(1.31,4.33) 210(23.6) 2.51(1.56,4.04) 66(34.2) 2.50(1.29,4.83)
Past-year STD
    No 776(98.9) 333(97.4) 1.00 879(98.0) 1.00 169(95.5) 1.00
    Yes 8(1.1) 10(2.6) 0.58(0.11,2.94) 17(2.0) 0.56(0.11,2.91) 11(4.5) 0.43(0.08,2.47)
Note: aOR stands for adjusted odds ratio, CI for confidence interval, SUD for substance use disorder and STD for sexually transmitted diseases.
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